SAN DIEGO, Oct. 2, 2014 /PRNewswire/ -- RESMED INC. (NYSE: RMD) today announced that it will report its first quarter of fiscal year 2015 results on Thursday, October 23, 2014, after the New York Stock Exchange market close. A press release with ResMed's results will be issued after 1:00 p.m. US Pacific Time and the company will host a webcast to discuss operating results and future outlook.
The earnings call is scheduled to begin at 1:30 p.m. US Pacific Time and the live webcast of the call can be accessed on ResMed's Investor Relations website at http://investor.resmed.com. Please go to this section of the website and click on the icon for the "Q1 2015 earnings webcast."
Please note that we are no longer using outside conference lines to access the earnings call.
International earnings webcast times will be:
|
9:30 p.m.
|
London
|
|
7:30 a.m.
|
Sydney, Australia (October 24, 2014)
|
A replay of the earnings webcast will be accessible on our website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately two hours after the webcast and will be accessible from October 23, 2014 until November 6, 2014 at:
US: 630-652-3042 Outside US: +1 630-652-3042 Passcode: 38203727
About ResMed
ResMed changes lives by developing, manufacturing and distributing medical equipment for treating, diagnosing, and managing sleep-disordered breathing, COPD, and other chronic diseases. We develop innovative products and solutions to improve the health and quality of life of those who suffer from these conditions, and we work to raise awareness of the potentially serious health consequences of untreated sleep-disordered breathing. For more information, please visit the company's website at www.resmed.com.
Contacts
Investors:
Agnes Lee
Senior Director, Investor Relations
(858) 836-5971
investorrelations@resmed.com
Media:
Bernadette McBrearty
Vice President, Global Marketing Communications
(858) 836-6786
news@resmed.com
Logo - http://photos.prnewswire.com/prnh/20140310/LA79234LOGO-a
SOURCE ResMed Inc.